Role of calcineurin in nicotine-mediated locomotor sensitization

Journal of Neuroscience

Volumn 27, Issue 32, 2007, Pages 8571-8580

  Addy, Nii A ^a   Fornasiero, Eugenio F ^a   Stevens, Tanya R ^a   Taylor, Jane R ^a   Picciotto, Marina R ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Calcineurin; DARPP32; Locomotor activity; Nicotine; Sensitization; Ventral tegmental area

Indexed keywords

CALCINEURIN; CALCINEURIN INHIBITOR; FK 506 BINDING PROTEIN; NICOTINE; PHOSPHOPROTEIN DARPP 32; RAPAMYCIN; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CHEMOSENSITIZATION; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; ENZYME INHIBITION; INFUSION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; RAT; VENTRAL TEGMENTUM;

ANIMALS; CALCINEURIN; CYCLOSPORINE; MALE; MOTOR ACTIVITY; NICOTINE; RATS; RATS, SPRAGUE-DAWLEY; VENTRAL TEGMENTAL AREA;

EID: 34547891517     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2601-07.2007     Document Type: Article

References (53)

1. Bahler M, Greengard P (1987) Synapsin I bundles F-actin in a phosphorylation-dependent manner. Nature 326:704-707.
2. Biala G (2003) Calcium channel antagonists suppress nicotine-induced place preference and locomotor sensitization in rodents. Pol J Pharmacol 55:327-335.
3. Brunzell D, Russell D, Picciotto M (2003) In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57Bl/6J mice. J Neurochem 84:1431-1441.
4. Centers for Disease Control and Prevention (2006) Tobacco use among adults - United States, 2005. MMWR Morb Mortal Wkly Rep 55:1145-1148.
5. Chen TC, Law B, Kondratyuk T, Rossie S (1995) Identification of soluble protein phosphatases that dephosphorylate voltage-sensitive sodium channels in rat brain. J Biol Chem 270:7750-7756.
6. Corrigall W, Coen K, Adamson K (1994) Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653:278-284.
7. Cousin M, Robinson P (2001) The dephosphins: dephosphorylation by calcineurin triggers synaptic vessible endocytosis. Trends Neurosci 24:659-665.
8. Day M, Olson P, Platzer J, Striessnig J, Surmeier D (2002) Stimulation of 5-HT(2) receptors in prefrontal pyramidal neurons inhibits Ca.(v)1.2 L type Ca(2+) currents via a PLCbeta/IP3/calcineurin signaling cascade. J Neurophysiol 87:2490-2504.
9. Donatsch P, Ryffel B (1986) Pharmacokinetics of cyclosporine in toxicological studies. Transplant Proc 28:71-76.
10. Ferrari R, Le Novere N, Picciotto M, Changeux J, Zoli M (2002) Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections. Eur J Neurosci 15:1810-1818.
11. Fu Y, Matta S, Gao W, Brower V, Sharp B (2000) Systemic nicotine stimulates dopamine release in nucleus accumbens: re-evaluation of the role of N-methyl-D-aspartate receptors in the ventral tegmental area. J Pharamcol Exp Ther 294:458-465.
12. Greengard P, Valtorta F, Czernik AJ, Benfenati F (1993) Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 259:780-785.
13. Greengard P, Allen PB, Nairn AC (1999) Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 23:435-447.
14. Grillner P, Svensson TH (2000) Nicotine-induced excitation of midbrain dopamine neurons in vitro involves ionotropic glutamate receptor activation. Synapse 38:1-9.
15. Groth RD, Dunbar RL, Mermelstein PG (2003) Calcineurin regulation of neuronal plasticity. Biochem Biophys Res Commun 311:1159-1171.
16. Hamada M, Higashi H, Nairn A, Greengard P, Nishi A (2004) Differential regulation of dopamine D1 and D2 signaling by nicotine in neostriatal neurons. J Neurochem 90:1094-1103.
17. Hart C, Kisro NA, Robinson SL, Ksir C (1996) Effects of the calcium channel blocker nimodipine on nicotine-induced locomotion in rats. Psychopharmacology (Berl) 128:359-361.
18. Hayashida S, Katsura M, Torigoe F, Tsujimura A, Ohkuma S (2005) Increased expression of L-type high voltage-gated calcium channel alpha1 and alpha2/delta subunits in mouse brain after chronic nicotine administration. Brain Res Mol Brain Res 135:280-284.
19. Hilfiker S, Benfenati F, Doussau F, Nairn A, Czernik A, Augustine G, Greengard P (2005) Structural domains involved in the regulation of transmitter release by synapsins. J Neurosci 25:2658-2669.
20. Hu XT, Ford K, White FJ (2005) Repeated cocaine administration decreases calcineurin (PP2B) but enhances DARPP-32 modulation of sodium currents in rat nucleus accumbens neurons. Neuropsychopharmacology 30:916-926.
21. Huttner WB, Schiebler W, Greengard P, De Camilli P (1983) Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation. J Cell Biol 96:1374-1388.
22. Imperato A, Mulas A, Di Chiara G (1986) Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol 132:337-338.
23. Iyaniwura T, Wright A, Balfour D (2001) Evidence that mesoaccumbens dopamine and locomotor responses to nicotine in the rat are influenced by pretreatment dose and strain. Psychopharmacology 158:73-79.
24. 2+-dependent glutamate release in isolated nerve terminals. J Neurosci 21:7944-7953.
25. Jovanovic JN, Czernik AJ, Fienberg AA, Greengard P, Sihra TS (2000) Synapsins as mediators of BDNF-enhanced neurotransmitter release. Nat Neurosci 3:323-329.
26. King MM, Huang CY, Chock PB, Nairn AC, Hemmings Jr HC, Chan KF, Greengard P (1984) Mammalian brain phosphoproteins as substrates for calcineurin. J Biol Chem 259:8080-8083.
27. Kita T, Okamoto M, Nakashima T (1992) Nicotine-induced sensitization to ambulatory stimulant effect produced by daily administration into the ventral tegmental area and the nucleus accumbens in rats. Life Sci 50:583-590.
28. Klink R, de Kerchove d'Exaerde A, Zoli M, Changeux JP (2001) Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J Neurosci 21:1452-1463.
29. Laviolette S, Van der Kooy D (2003) Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area. Mol Psychiatry 8:50-59.
30. Laviolette S, Van der Kooy D (2004) The neurobiology of nicotine addiction: bridging the gap from the molecules to behavior. Nat Rev Neurosci 5:55-65.
31. Lee JI, Ahnn J (2004) Calcineurin in animal behavior. Mol Cells 17:390-396.
32. Lisman J (1989) A mechanism for the Hebb and the anti-Hebb processes underlying learning and memory. Proc Natl Acad Sci USA 86:9574-9578.
33. Liu J, Farmer Jr JD, Lane WS, Friedman J, Weissman I, Schreiber SL (1991) Calcineurin is a common target of cyclophilin-cyclosporin A and FKBPFK506 complexes. Cell 66:807-815.
34. Lu YM, Mansuy IM, Kandel ER, Roder J (2000) Calcineurin-mediated LTD of GABAergic inhibition underlies the increased excitability of CA1 neurons associated with LTP. Neuron 26:197-205.
35. Lynch WJ, Kiraly DD, Caldarone BJ, Picciotto MR, Taylor JR (2006) Effect of cocaine self-administration on striatal PKA-regulated signaling in male and female rats. Psychopharmacology (Berl) 191:263-271.
36. Mansvelder H, Keath J, McGehee D (2002) Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33:905-919.
37. Marszalec W, Yeh JZ, Narahashi T (2005) Desensitization of nicotine acetylcholine receptors: modulation by kinase activation and phosphatase inhibition. Eur J Pharmacol 514:83-90.
38. McGehee DS, Role LW (1995) Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 57:521-546.
39. Nakayama H, Numakawa T, Ikeuchi T, Hatanaka H (2001) Nicotine-induced phosphorylation of extracellular signal-regulated protein kinase and CREB in PC12h cells. J Neurochem 79:489-498.
40. Panagis G, Nisell M, Nomikos GG, Chergui K, Svensson TH (1996) Nicotine injections into the ventral tegmental area increase locomotion and Fos-like immunoreactivity in the nucleus accumbens of the rat. Brain Res 730:133-142.
41. Picciotto M (1998) Common aspects of the action of nicotine and other drugs of abuse. Drug Alcohol Depend 51:165-172.
42. Saal D, Dong Y, Bonci A, Malenka R (2003) Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37:577-582.
43. Stevens T, Krueger S, Fitzsimonds R, Picciotto M (2003) Neuroprotection by nicotine in mouse primary cortical cultures involves activation of calcineurin and L-type calcium channel inactivation. J Neurosci 23:10093-10099.
44. Svensson TH, Mathe JM, Nomikos GG, Schilstrom B (1998) Role of excitatory amino acids in the ventral tegmental area for central actions of non-competitive NMDA-receptor antagonists and nicotine. Amino Acids 14:51-56.
45. Toth E, Sershen H, Hashim A, Vizi ES, Lajtha A (1992) Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: role of glutamic acid. Neurochem Res 17:265-271.
46. Valjent E, Pascoli V, Svenningsson P, Paul S, Enslen H, Corvol J, Stipanovich A, Caboche J, Lombroso P, Nairn A, Greengard P, Herve D, Girault J (2005) Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc Natl Acad Sci USA 102:491-496.
47. Wang F, Chen H, Steketee JD, Sharp BM (2007) Upregulation of ionotropic glutamate receptor subunits within specific mesocorticolimbic regions during chronic nicotine self-administration. Neuropsychopharmacology 32:103-109.
48. Wang J, Liu S, Haditsch U, Tu W, Cochrane K, Ahmadian G, Tran L, Paw J, Wang Y, Mansuy I, Salter MM, Lu YM (2003) Interaction of calcineurin and type-A GABA receptor γ2 subunits produces long-term depression at CA1 inhibitory synapses. J Neurosci 23:826-836.
49. Winder DG, Sweatt JD (2001) Phosphatases in hippocampal synaptic plasticity. Nat Rev Neurosci 2:461-474.
50. Yakel JL (1997) Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription. Trends Pharmacol Sci 18:124-134.
51. Yu DY, Luo J, Bu F, Zhang W, Wei Q (2006) Effects of cyclosporin A, FK506 and rapamycin on calcineurin phosphatase activity in mouse brain. IUBMB Life 58:429-433.
52. Zachariou V, Sgambato-Faure V, Sasaki T, Svenningsson P, Berton O, Fienberg AA, Nairn AC, Greengard P, Nestler EJ (2006) Phosphorylation of DARPP-32 at threonine-34 is required for cocaine action. Neuropsychopharmacology 31:555-562.
53. Zhu H, Lee M, Guan F, Agatsuma S, Scott D, Fabrizio K, Fienberg A, Hiroi N (2005) DARPP-32 phosphorylation opposes the behavioral effects of nicotine. Biol Psychiatry 58:981-989.